Skip to content
Clinical Trials – home
Sumitomo Pharma Co. Ltd.
Sponsor

Sumitomo Pharma Co. Ltd.

6-8 Doshomachi 2 Chome, Chuo Ku, 541-0045

About the sponsor

Clinical research in acutely psychotic schizophrenia focuses on symptom control, with attention to positive and negative syndrome burden and overall psychiatric stabilization.

  • Schizophrenia
  • Acute psychosis
  • PANSS symptom assessment

The sponsor’s activity in this area reflects interest in treatments for severe mental health conditions requiring rapid clinical management.

About Specializations

Sumitomo Pharma Co. Ltd. runs clinical trials in conditions such as Schizophrenia, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Schizophrenia

Not recruiting
Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Ulotaront
  • Sponsor:Sumitomo Pharma Co. Ltd.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.